Cincinnati Children's Hospital Medical Center

Tabeeze Named TIME's List Of The Best Inventions of 2023

Retrieved on: 
Wednesday, November 1, 2023
TIME, Cincinnati Children's Hospital Medical Center, GOTS, Creativity, Multimedia, Partnership, NICU, Hospital, Planet, AI, Invention, Parent, Toy, Amazon

LOS ANGELES, Nov. 1, 2023 /PRNewswire/ -- TIME has revealed its annual list of the Best Inventions, which features 200 extraordinary innovations changing our lives including Tabeeze (pronounced TAB-ease), founded by architect and mother Carrie Shaltz Haslup, Tabeeze is a Los Angeles-based company providing parents and their children with innovative, "fuss-free" clothing solutions that adhere to the most stringent sustainable production practices possible.

Key Points: 
  • "Receiving recognition as one of TIME's Best Inventions of 2023 is an incredible honor and achievement," said Carrie Shaltz Haslup, Founder and CEO of Tabeeze.
  • We believe that form follows function and we're constantly innovating to make the world more comfortable for our littlest inhabitants."
  • Tabeeze was born out of Shaltz Haslup seeing her brother and sister-in-law struggle to do skin-to-skin with their baby.
  • The Tabeeze Bottom-Up Bodysuit, which has also won a 2022 JPMA Award for Most Innovative Baby Products, is available on Amazon ($20).

Positive Phase 1 Data for Blue Lake Biotechnology’s Intranasal RSV Vaccine Published in Science Advances

Retrieved on: 
Wednesday, October 25, 2023
Health, Infectious Diseases, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, RSV, Global health, Vaccine, Mortality, MD, Disease, Infant, Science Advances, Immune system, Infection, Cincinnati, Cincinnati Children's Hospital Medical Center

Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing PIV5-vectored vaccines that harness the full breadth of the immune system to protect against serious infectious diseases, announced the publication of positive Phase 1 clinical trial results of its intranasal RSV vaccine candidate BLB201 in Science Advances .

Key Points: 
  • Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing PIV5-vectored vaccines that harness the full breadth of the immune system to protect against serious infectious diseases, announced the publication of positive Phase 1 clinical trial results of its intranasal RSV vaccine candidate BLB201 in Science Advances .
  • Of all intranasal RSV vaccine candidates that have so far been evaluated in adults, BLB201 has generated the most robust immune responses.
  • The Phase 1 results show that BLB201 is a promising intranasal vaccine candidate for the elderly.
  • To explore this potential, Blue Lake is now actively enrolling a Phase 1/2a study in infants and children between the ages of six to 59 months in the U.S.

First Student Launches New Student Services Division to Ensure Exceptional Student Experience on Journey to and from School

Retrieved on: 
Wednesday, October 25, 2023
LRE, Student Services, First Student, Transport, Individuals with Disabilities Education Act, Cincinnati Children's Hospital Medical Center, Hospital, Student, Disability studies, IDEA, Parent, Nursing

CINCINNATI, Oct. 25, 2023 /PRNewswire/ -- Today, First Student, the largest provider of school transportation in North America, launched its new Student Services division to ensure a positive student experience on every journey to and from school.

Key Points: 
  • CINCINNATI, Oct. 25, 2023 /PRNewswire/ -- Today, First Student, the largest provider of school transportation in North America, launched its new Student Services division to ensure a positive student experience on every journey to and from school.
  • "At First Student, providing an exceptional experience for all students, regardless of individual needs, is our utmost priority," said Will McDermott, head of Student Services.
  • The Student Services division works closely alongside behavioral experts, district leaders and parents to improve each student's experience.
  • In addition to serving school districts already contracted with First Student, the new Student Services division will be available on a consulting basis for all districts, ensuring broad access to these industry-leading services to improve the transportation experience for students.

Phoenix Children's Expands Research Team with Scientist Pioneering New Childhood Cancer Treatments

Retrieved on: 
Tuesday, October 17, 2023
Physician, Lung cancer, Pediatric nursing, Doctor of Philosophy, Phoenix Children's Hospital, American Cancer Society, American Cancer Society Cancer Action Network, University of Arizona College of Medicine – Tucson, Cardiology, Neurology, Proton, Pharmacist, Nanoparticle, University, Biostatistics, The Ride to Conquer Cancer, Patient, University of Illinois at Chicago, Nursing, Research, Conquer, Cincinnati Children's Hospital Medical Center, Molecular biology, Medicine, Bangladesh Technical Education Board, Metastasis, Neoplasm, Vinnytsia National Medical University. N. I. Pirogov, Chronic lung disease, Pharmaceutical industry, Dentistry, MD, Cancer

PHOENIX, Oct. 17, 2023 /PRNewswire/ -- Phoenix Children's, one of the nation's fastest-growing pediatric health systems, continues to strengthen its focus on pediatric research with the hire of Tanya Kalin, MD, PhD, a renowned scientist focused on pioneering effective treatments for pediatric cancers with fewer negative side effects for children. Dr. Kalin also serves as vice chair of translational research for the Phoenix Children's Center for Cancer and Blood Disorders, and as a professor of Child Health at the University of Arizona College of Medicine – Phoenix.

Key Points: 
  • Dr. Kalin also serves as vice chair of translational research for the Phoenix Children's Center for Cancer and Blood Disorders , and as a professor of Child Health at the University of Arizona College of Medicine – Phoenix.
  • Dr. Kalin, who assumed her new post in recent weeks, comes to Phoenix Children's from Cincinnati Children's, where she founded and directed her namesake Kalin Research Lab.
  • Two members of her lab also are moving to Phoenix Children's to continue their research with Dr. Kalin.
  • Research underway at Phoenix Children's consists of more than 700 active studies, 640 research investigators and 90 research staff members including research scientists, associates, biostatisticians, pharmacists, nurses, coordinators and assistants.

Early Behavioral Health Problems Need Earlier Interventions

Retrieved on: 
Monday, October 16, 2023
Parent, Health, Male, Doctor of Philosophy, Family, DOI, Caregiver, American Academy, Behavioral Problems, Pediatrics, Medicaid, Risk, MPH, Chart, JAMA Pediatrics, Tantrum, Artificial intelligence, Mental health, Strength, Cincinnati Children's Hospital Medical Center, Pediatrics (journal), Mental, Child Behavior Checklist, Mother, Depression, SDQ, Integrative behavioral couples therapy, Child, Invention, Emotional and behavioral disorders, Research, Housing, Nursing, Birth control, MD

CINCINNATI, Oct. 16, 2023 /PRNewswire/ -- A six-year study that analyzed data from a 25-question screening tool found alarming evidence of unhealthy behavioral trajectories starting as early as age 2 among families affected by low income and other social stressors.

Key Points: 
  • However, the early ages of onset and severity of behavioral problems were unexpected.
  • "The elevated results we saw reflect significant behavioral problems starting at very early ages," Ammerman says.
  • That's why--until care resources are dramatically expanded across the country--the early steps for addressing behavioral health risks need to focus more on preventive interventions to promote healthy behavioral development.
  • The recently announced Mental and Behavioral Health Institute at Cincinnati Children's plans to accelerate expansion of integrated behavioral health services into community-based pediatric practices.

Bexion Pharmaceuticals, Inc. Appoints Dr. Catherine Pearce, DHSc, MBA, to Board of Directors

Retrieved on: 
Tuesday, October 10, 2023
Chemotherapy-induced peripheral neuropathy, Doctor of Health Science, Schizophrenia, Xavier University, MBA, Compugen (company), Nova Southeastern University, Drug development, CIPN, Doctorate, Outline of health sciences, BS, Biotechnology, Medicine, Hospital, Teva Pharmaceuticals, Cincinnati Children's Hospital Medical Center, AstraZeneca, Growth, Collection, Marketing, Trustee, Medical Center, Patient, Pharmaceutical industry, Medpace

Dr. Pearce led hundreds of global clinical trials at Medpace, where she later built out business development and marketing teams.

Key Points: 
  • Dr. Pearce led hundreds of global clinical trials at Medpace, where she later built out business development and marketing teams.
  • At Teva Pharmaceuticals, Dr. Pearce evaluated generics for repurposing, leading to the approval of Uzedy for the treatment of schizophrenia.
  • Catherine Pearce, DHSc, MBA, stated, "I am excited to be joining Bexion at this critical inflection point in their development of BXQ-350.
  • The health system, which licensed the technology to Bexion, stated: "Catherine is an accomplished biotech leader in both Cincinnati and the industry at large.

Urban League Unveils the Holloman Center for Social Justice in Avondale Town Center

Retrieved on: 
Monday, October 2, 2023
Heart, Social justice, Policy, Health equity, Data collection, Cincinnati Children's Hospital Medical Center, CSJ, Fifth Third Bank, National Urban League, Jewish Community Relations Council of Minnesota and the Dakotas, Hospital, Social, Mental health, Management, Nursing

CINCINNATI, Oct. 2, 2023 /PRNewswire/ -- In August, the Urban League of Greater Southwestern Ohio (ULGSO) proudly unveiled the Holloman Center for Social Justice (CSJ) in Avondale Town Center, following an inaugural ribbon-cutting ceremony presented by Fifth Third Bank. The ceremony was graced by Commissioner Alicia Reece, Mayor Aftab Pureval, former ULGSO presidents Eddie Keon and Donna Jones Baker, YWCA Cincinnati's Rickell Howard Smith, who is also the inaugural executive director for CSJ, and members of the Avondale community.

Key Points: 
  • CINCINNATI, Oct. 2, 2023 /PRNewswire/ -- In August, the Urban League of Greater Southwestern Ohio (ULGSO) proudly unveiled the Holloman Center for Social Justice (CSJ) in Avondale Town Center, following an inaugural ribbon-cutting ceremony presented by Fifth Third Bank.
  • Kala Gibson, Executive Vice President and Chief Corporate Responsibility Officer of Fifth Third, remarked, " Our support for the Holloman Center for Social Justice reflects our unwavering dedication to creating a more just and equitable society for all.
  • We want to ensure that social justice remains at the heart of a better future for the communities we serve."
  • The Holloman Center symbolizes our unyielding devotion to social justice in historically underserved communities."

First Migraine Neuroband Addressing Unmet Needs of Adolescents to Debut at 2023 Child Neurology Society Annual Meeting

Retrieved on: 
Thursday, September 28, 2023
REN, University Hospital, New Orleans, Quality of life, CNS, Cincinnati Children's Hospital Medical Center, Risk, CPM, Hospital, Texas Tech University Health Sciences Center El Paso, Birth control, Pharmaceutical industry, Cheese, Migraine, MD

NETANYA, Israel and BRIDGEWATER, N.J., Sept. 28, 2023 /PRNewswire/ -- Theranica, a neuromodulation therapeutics company, is exhibiting and presenting at the upcoming 52nd Annual Child Neurology Society Meeting (CNS)(Booth #209), where they will present Nerivio®, the first and only dual-use (acute and preventive) migraine neuroband purpose-built for adolescents with migraine disease.

Key Points: 
  • "Reducing disability and frequency of migraine attacks in children and adolescents improves their quality of life and potentially decreases risk of conversion to chronic migraine.
  • The recent expanded indication of the Nerivio migraine neuroband represents a distinctive dual-use treatment to reduce the occurrence of migraine episodes and relief their symptoms upon onset."
  • Migraine disease affects 1 billion people worldwide, 10 percent of which are children, with far-reaching consequences that can't be ignored.
  • According to Alon Ironi, the CEO and co-founder of Theranica, "Our goal at Theranica has always been focused on addressing significant unmet clinical needs.

Cincinnati Children's Launches Advanced Leukemia Therapies and Research Center

Retrieved on: 
Tuesday, September 26, 2023
University, Life, Education, Health, Bone marrow, The Hospital Research Foundation, Research, Cincinnati Children's Hospital Medical Center, Cell, Doctor of Philosophy, Science, U.S. News & World Report, AML, UC, MD, Patient, Division, Leukemia, FDA, News, Pharmaceutical industry, Nursing, Dentistry, Pediatrics, Daunorubicin/cytarabine, Cancer

CINCINNATI, Sept. 26, 2023 /PRNewswire/ -- Cincinnati Children's, the top ranked pediatric hospital and top ranked cancer program in the country by U.S. News & World Report, continues to break new ground with the launch of the first of its kind Advanced Leukemia Therapies and Research Center. The center will integrate the expertise of the world class research and clinical programs at Cincinnati Children's and increase patient access to cutting edge clinical trials.

Key Points: 
  • "We want to improve the outcomes of Acute Myeloid Leukemia (AML) patients by spearheading innovative and transformative research that will bring new treatment options to blood cancer patients of any age," said Daniel Starczynowski, PhD, director of the Cincinnati Children's Advanced Leukemia Therapies and Research Center, associate director of the Cancer and Blood Diseases Institute and associate director for basic science research at the University of Cincinnati Cancer Center.
  • Cincinnati Children's formed the Advanced Leukemia Therapies and Research Center to accelerate more scientific discoveries like this to bring more curative options to AML patients.
  • The addition of the Advanced Leukemia Therapies and Research Center further confirms Cincinnati Children's as a global leader in cancer care, research and education.
  • "The Advanced Leukemia Therapies and Research Center and the progress we are making there sets Cincinnati Children's apart from other pediatric academic research centers."

Moms' Ability to 'Remember' Prior Pregnancies Suggests New Strategies for Preventing Complications

Retrieved on: 
Thursday, September 21, 2023
Vaccine, Inflammation, Infection, Tissue, Heart, US Food Sovereignty Alliance, Human, Pregnancy, University, Genetics, Fetus, University of Cincinnati, Immunity, Woman, Research, Cincinnati Children's Hospital Medical Center, Child, Doctor of Philosophy, Autoimmunity, Uterus, Mother, Transplant, Parity, RSV, Division, Risk, Organ transplantation, Preterm birth, Immune system, Pre-eclampsia, Stillbirth, Mouse, Liver, Infant, Mortality, Memory, Food, Dietary supplement, Birth control, Pharmaceutical industry, Science, Nature, MD, Cell

"By investigating how prior pregnancy changes the outcomes of future pregnancies--or in other words how mothers remember their babies--our findings add a new dimension to our understanding of how pregnancy works," Way says. "Nature has designed built-in resiliency in mothers that generally reduces the risk of preterm birth, preeclampsia, and stillbirth in women who have a prior healthy pregnancy. If we can learn ways to mimic these strategies, we may be better able to prevent complications in high-risk pregnancies."

Key Points: 
  • New insights about how mothers' bodies remember prior pregnancies may help reduce complication risks.
  • "Nature has designed built-in resiliency in mothers that generally reduces the risk of preterm birth, preeclampsia, and stillbirth in women who have a prior healthy pregnancy.
  • If we can learn ways to mimic these strategies, we may be better able to prevent complications in high-risk pregnancies."
  • Considering parity or the outcomes of prior pregnancy on the outcomes of future pregnancies add an exciting new dimension for investigating how pregnancy works," Way says.